Showing results (221-230 of 297) with videos related to
Sort By:
Pageof 30
Pharmacogenetics and Genomics|September 27, 2021
Anesthesia providers as stakeholders to adoption of pharmacogenomic information in perioperative careTien M Truong, Jeffrey L Apfelbaum, Emily Schierer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Relationship of EGFR mutations, expression, amplification, and polymorphisms to epidermal growth factor receptor inhibitors in the NCI60 cell linesWanqing Liu, Xiaolin Wu, Wei Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Phase I study of inhaled Doxorubicin for patients with metastatic tumors to the lungsGregory A Otterson, Miguel A Villalona-Calero, Sunil Sharma, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
A phase I study of cantuzumab mertansine administered as a single intravenous infusion once weekly in patients with advanced solid tumorsPaul R Helft, Richard L Schilsky, Frank J Hoke, et al.American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|March 12, 2014
Adoption of a clinical pharmacogenomics implementation program during outpatient care--initial results of the University of Chicago "1,200 Patients Project"Peter H O'Donnell, Keith Danahey, Michael Jacobs, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2014
Phase I dose-escalation study of onartuzumab as a single agent and in combination with bevacizumab in patients with advanced solid malignanciesRavi Salgia, Premal Patel, John Bothos, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2013
Evaluation of food effect on pharmacokinetics of vismodegib in advanced solid tumor patientsManish R Sharma, Theodore G Karrison, Bethany Kell, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agentsJanet E Dancey, Kevin K Dobbin, Susan Groshen, et al.Investigational New Drugs|December 9, 2014
A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasiaOlatoyosi Odenike, Anna Halpern, Lucy A Godley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2006
Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762)Stuart M Lichtman, Donna Hollis, Antonius A Miller, et al.Pageof 30